Skip to Main Content

Print | Bookmark | Email | Font Size: + |

September 9, 2024

October 2024 HCPCS Updates – New, Revised, and Discontinued HCPCS Codes and Modifiers

The following information is based on the October 2024 Healthcare Common Procedure Coding System (HCPCS) file. There are updates that will be effective October 1, 2024. It’s important to remember that the appearance of a HCPCS code is not an indication of coverage by the DME MAC.

This following list contains added HCPCS codes that will be effective October 1, 2024.

HCPCS DESCRIPTION
A4543 Supplies for transcutaneous electrical nerve stimulator, for nerves in the auricular region, per month
A4544 Electrode for external lower extremity nerve stimulator for restless legs syndrome
A4545 Supplies and accessories for external tibial nerve stimulator (e.g., socks, gel pads, electrodes, etc.), needed for one month
A7021 Supplies and accessories for lung expansion airway clearance, continuous high frequency oscillation, and nebulization device (e.g., handset, nebulizer kit, biofilter)
E0469 Lung expansion airway clearance, continuous high frequency oscillation, and nebulization device
E0683 Non-pneumatic, non-sequential, peristaltic wave compression pump
E0715 Intravaginal device intended to strengthen pelvic floor muscles during kegel exercises
E0716 Supplies and accessories for intravaginal device intended to strengthen pelvic floor muscles during kegel exercises
E0721 Transcutaneous electrical nerve stimulatory, stimulates nerves in the auricular region
E0737 Transcutaneous tibial nerve stimulator, controlled by phone application
E0743 External lower extremity nerve stimulator for restless legs syndrome, each
E0767 Intrabuccal, systemic delivery of amplitude-modulated, radiofrequency electromagnetic field device, for cancer treatment, includes all accessories
E2513 Accessory for speech generating device, electromyographic sensor
E3200 Gait modulation system, rhythmic auditory stimulation, including restricted therapy software, all components and accessories, prescription only
J0138 Injection, acetaminophen 10 mg and ibuprofen 3 mg
J1171 Injection, hydromorphone, 0.1 mg
J1749 Injection, iloprost, 0.1 mcg
J2002 Injection, lidocaine hcl in 5% dextrose, 1 mg
J2003 Injection, lidocaine hydrochloride, 1 mg
J2004 Injection, lidocaine hcl with epinephrine, 1 mg
J2252 Injection, midazolam in 0.8% sodium chloride, intravenous, not therapeutically equivalent to j2250, 1 mg
J2253 Injection, midazolam (seizalam), 1 mg
J2601 Injection, vasopressin (baxter), 1 unit
J8522 Capecitabine, oral, 50 mg
J8541 Dexamethasone (hemady), oral, 0.25 mg
J9329 Injection, tislelizumab-jsgr, 1mg
L1006 Scoliosis orthosis, sagittal-coronal control provided by a rigid lateral frame, extends from axilla to trochanter, includes all accessory pads, straps and interface, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise
L1653 Hip orthosis, bilateral thigh cuffs with adjustable abductor spreader bar, adult size, prefabricated, off the shelf
L1821 Knee orthosis, elastic with condylar pads and joints, with or without patellar control, prefabricated, off the shelf
L8720 External lower extremity sensory prosthesis, cutaneous stimulation of mechanoreceptors proximal to the ankle, per leg
L8721 Receptor sole for use with l8720, replacement, each
Q0519 Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription injectable drug, per 30-days
Q0520 Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription injectable drug, per 30-days
Q5135 Injection, tocilizumab-aazg (tyenne), biosimilar, 1 mg
Q5136 Injection, denosumab-bbdz (jubbonti/wyost), biosimilar, 1 mg

The following HCPCS codes have description/verbiage changes that will be effective October 1, 2024.

HCPCS DESCRIPTION
A4271 Integrated lancing and blood sample testing cartridges for home blood glucose monitor, per 50 tests
E0739 Rehabilitation system with interactive interface providing active assistance in rehabilitation therapy, includes all components and accessories, motors, microprocessors, sensors
J2251 Injection, midazolam in 0.9% sodium chloride, intravenous, not therapeutically equivalent to j2250, 1 mg
J9172 Injection, docetaxel (docivyx), 1 mg
L1652 Hip orthosis, bilateral thigh cuffs with adjustable abductor spreader bar, adult size, prefabricated, includes fitting and adjustment, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise
L1820 Knee orthosis, elastic with condylar pads and joints, with or without patellar control, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise
Q0516 Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 30-days
Q0517 Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 60-days
Q0518 Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 90-days

The following listing has discontinued HCPCS codes, along with the cross-walked HCPCS codes (if applicable). Please note, not all discontinued HCPCS codes will have a cross-walked HCPCS code.

HCPCS DISCONTINUE DATE CROSSWALK HCPCS CODE
J1170 09/30/2024  
J2001 09/30/2024  
J8520 09/30/2024  
J8521 09/30/2024  
J9258 09/30/2024  

spacer

26 Century Blvd Ste ST610, Nashville, TN 37214-3685 © CGS Administrators, LLC. All Rights Reserved